Showing 241-258 of 258 for: EBMG evidence summaries > Pharmacotherapeutics 
- Tiagabine add-on for drug-resistant partial epilepsy
EBMG evidence summaries, 15-Nov-2010
Tiagabine reduces seizures frequency but is associated with some side effects when used as an add-on medication for people with drug-resistant localised seizures.
- Topical corticosteroids for aphthous stomatitis
EBMG evidence summaries, 9-Aug-2007
Topical corticosteroids appear to be effective in reducing pain associated with recurrent aphthous ulceration and they appear to reduce the time with ulcers.
- Topical non-steroidal anti-inflammatory drugs (NSAIDs) for treating lateral elbow pain
EBMG evidence summaries, 30-May-2007
Non-steroidal anti-inflammatory drugs appear to have some effect administered topically for lateral elbow pain.
- Topical NSAIDs for acute pain in adults
EBMG evidence summaries, 19-Jan-2011
Topical non-steroidal anti-inflammatory drugs (NSAIDs) diclofenac, ibuprofen, ketoprofen and piroxicam are effective for pain relief in acute musculoskeletal conditions, without systemic adverse events.
- Topical treatments for seasonal allergic conjunctivitis
EBMG evidence summaries, 2-Apr-2007
Topical mast cell stabilisers and topical antihistamines appear to be more effective than placebo for allergic conjunctivitis.
- Treating oral candidiasis in cancer patients
EBMG evidence summaries, 16-Aug-2010
Ketoconazole may be effective in eradicating oral candidiasis in patients with cancer receiving either chemotherapy or radiotherapy treatment. For clotrimazole, 50 mg dose appears to be more effective than 10 mg dose.
- Treatment of early Lyme disease
EBMG evidence summaries, 20-Mar-2003
Oral beta-lactam antibiotics and oral tetracyclines appear to be effective against early Lyme disease. Oral macrolides are probably not effective.
- Treatment of tinnitus
EBMG evidence summaries, 28-Sep-2012
Tricyclic antidepressants might possibly be slightly beneficial in the treatment of tinnitus, although the evidence is insufficient.
- Treatments for infantile colic
EBMG evidence summaries, 27-Dec-2007
The elimination of cow’s milk protein and behavioural interventions (reduced stimulation in combination with permission to leave the infant) are effective treatments for infantile colic. Anticholinergic drug dicyclomine is also effective but is not recomm
- Tricyclic and related drugs for nocturnal enuresis in children
EBMG evidence summaries, 20-Feb-2004
Treatment with tricyclic drugs appears to be associated with a reduction of about one wet night per week.
- Tricyclic antidepressant for depression in children and adolescents
EBMG evidence summaries, 28-Dec-2006
Tricyclic antidepressants appear not to be more efficient than placebo in the treatment of depression in children. They may be marginally effective in adolescents.
- Trifluoperazine for schizophrenia
EBMG evidence summaries, 13-Apr-2004
Trifluoperazine has antipsychotic efficacy similar to other commonly used neuroleptics for people with schizophrenia. Extrapyramidal adverse effects may be more likely than with low potency older generation antipsychotics.
- Valproate for schizophrenia
EBMG evidence summaries, 1-Nov-2006
Using valproate as an adjunct to antipsychotic medication may not have an effect on the participants' global state or general mental state. Adding valproate to antipsychotics may have limited effect in speeding the onset of action.
- Vitamin E for intermittent claudication
EBMG evidence summaries, 21-Apr-2010
There is insufficient evidence to determine whether vitamin E is an effective treatment for intermittent claudication.
- Vitamin E supplementation and cardiovascular events in high-risk patients
EBMG evidence summaries, 10-Apr-2007
Vitamin E supplementation has no effect on cardiovascular outcomes.
- Vitamin E supplementation in pregnancy
EBMG evidence summaries, 29-Dec-2005
Vitamin E supplementation in pregnancy appears not to reduce the risk of pregnancy complications.
- Vitamin K antagonists or low-molecular weight heparin for venous thromboembolism
EBMG evidence summaries, 21-Dec-2012
Low-molecular weight heparins appear to be equally effective and safer as vitamin K antagonists in the long-term treatment of symptomatic venous thromboembolism.
- Zuclopenthixol dihydrochloride for schizophrenia
EBMG evidence summaries, 18-May-2006
Oral zuclopenthixol may have some clinical advantage over other older antipsychotic drugs at least in the short term and remains a choice if older generation drugs are indicated.
